Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Long-Term Debt Repayments (2017 - 2023)

Ocular Therapeutix (OCUL) has 5 years of Long-Term Debt Repayments data on record, last reported at $2.1 million in Q2 2021.

  • For Q2 2021, Long-Term Debt Repayments changed N/A year-over-year to $2.1 million; the TTM value through Dec 2023 reached $2.1 million, changed N/A, while the annual FY2023 figure was $2.0 million, N/A changed from the prior year.
  • Long-Term Debt Repayments reached $2.1 million in Q2 2021 per OCUL's latest filing, roughly flat from $2.1 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $2.1 million in Q2 2021 and bottomed at $1.0 million in Q1 2018.
  • Average Long-Term Debt Repayments over 3 years is $1.6 million, with a median of $1.5 million recorded in 2018.
  • The widest YoY moves for Long-Term Debt Repayments: up 20.85% in 2018, down 20.85% in 2018.
  • A 3-year view of Long-Term Debt Repayments shows it stood at $1.3 million in 2017, then increased by 18.69% to $1.5 million in 2018, then surged by 35.06% to $2.1 million in 2021.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Repayments were $2.1 million in Q2 2021, $2.1 million in Q1 2021, and $1.5 million in Q4 2018.